img
img
Scott Kupor
Growth

Scott Kupor

Investing

About

Scott Kupor is an investing partner focused on growth-stage companies building in the bio and healthcare industries, manages the firm’s investor relations team, and is responsible for the firm’s growth initiatives. 

Scott was the first employee at Andreessen Horowitz and managed the firm’s growth from $300 million in AUM to more than $40 billion. Prior to joining the firm, Scott worked as vice president and general manager of software-as-a-service at Hewlett Packard. Before that, he held numerous executive management positions at Opsware, including senior vice president of global field operations, vice president of financial planning and vice president of corporate development. Prior to Opsware, Scott represented software companies in both financing and mergers and acquisitions transactions at Credit Suisse First Boston and Lehman Brothers. 

Scott is the author of the Wall Street Journal bestselling book, Secrets of Sand Hill Road: Venture Capital and How to Get It, and serves on the boards of Cedar, Formation Bio, Foursquare, Headway, Labster, SnapLogic, Talkiatry, Tanium, and Ultima. He also served as chairman of the board for the National Venture Capital Association.

Scott graduated Phi Beta Kappa from Stanford University with a bachelor’s degree in public policy with honors and distinction. He also holds a law degree with distinction from Stanford University and is a member of the State Bar of California.

Latest Content

  • Investing in InfinitusNew
    Scott Kupor

    Infinitus is tackling this problem by building the first AI platform specifically designed to automate healthcare phone calls and data gathering.

  • Pharma represents one of the biggest industries in the world. The top 10 pharma companies account for over $3.4T in aggregate market cap, and last year, the US alone spent more than $700B on pharmaceuticals and prescript...

  • Talkiatry addresses the acute end of the behavioral health market—psychiatric care—by offering virtual treatment covered by patients’ insurance.

  • Healthtech: Show Your Magic
    Jay Rughani, Mehul Mehta, Julie Yoo, and Scott Kupor

    The public market situation for healthtech can seem pretty depressing. Recently IPOed healthtech stocks are underperforming the broader market, with some falling 95%+ from their IPO—meanwhile, more traditional companies...

  • How we can improve the overall state of the IPO markets, economic growth, and retail access to capital.

go to top